Antihelminthic benzimidazoles are novel HIF activators that prevent oxidative neuronal death via binding to tubulin
Aims: Pharmacological activation of the adaptive response to hypoxia is a therapeutic strategy of growing interest for neurological conditions, including stroke, Huntington's disease, and Parkinson's disease. We screened a drug library with known safety in humans using a hippocampal neurob...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , |
| التنسيق: | article |
| منشور في: |
2014
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/6133 http://dx.doi.org/ 10.1089/ars.2013.5595 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://online.liebertpub.com/doi/abs/10.1089/ars.2013.5595 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|